Pharming Group

Dutch biotech Pharming Group is in the news after reporting black figures and higher revenue in its third-quarter results. The company also presented positive study results for its drug leniolisib at a medical conference. Investors reacted with a rising share price, though analysts note the real test still lies ahead in the US regulatory process.